AxioMed Submits Final Module III to FDA

AxioMed Freedom Lumbar Total Disc

On August 8, 2022, AxioMed submitted to FDA all of the required documents for Module III, the final Module containing all of the data tables comparing AxioMed to Centinel Spine's prodisc as the control. The final step for AxioMed to get U.S. market approval will be an FDA site inspection of the cleanroom manufacturing facilities in...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us